Organon wins FDA nod to expand use of Nexplanon birth control implant

Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...
The Cardiology Advisor

Nexplanon Approved for Pregnancy Prevention for Up to 5 Years

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
Zacks Investment Research on MSN

Organon secures FDA approval extending NEXPLANON use to five years

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
WBUR

Primary care physicians can help solve the current birth control crisis

Just before the holidays, a patient was in my office for what I thought was going to be a routine appointment. After completing the exam, however, we started talking about what was really on her mind.